TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26803397

Group type: EXPERIMENTAL
Intervention: Citalopram (12-week course)
Number of subjects: 4041

Group type: EXPERIMENTAL
Intervention: Escitalopram (treatment group in COMED, n=151)
Number of subjects: 4041

Group type: EXPERIMENTAL
Intervention: Escitalopram-buproprion (combined treatment group in COMED, n=134)
Number of subjects: 4041

Group type: EXPERIMENTAL
Intervention: Venlafaxine-mirtazapine (combined treatment group in COMED, n=140)
Number of subjects: 4041
Study: 26011971

Group type: EXPERIMENTAL
Intervention: LASEK
Number of subjects: 30

Group type: COMPARATOR
Intervention: T-PRK
Number of subjects: 30
Study: 24985393

Group type: EXPERIMENTAL
Intervention: Yoga intervention (10-week duration)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 22
Study: 22917446

Group type: EXPERIMENTAL
Intervention: Legacy for ChildrenTM group-based parenting intervention model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 0
Study: 21056807

Group type: EXPERIMENTAL
Intervention: IV diclofenac 37.5 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: ketorolac 30 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: oral acetylsalicylic acid (ASA) 325 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: oral diclofenac 50 mg
Number of subjects: 30
Study: 17693428

Group type: EXPERIMENTAL
Intervention: Orthodontic treatment (appliance removal)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (untreated group)
Number of subjects: 25
Study: 15653006

Group type: EXPERIMENTAL
Intervention: Vaginal estriol 0.5 mg/day
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 12410188

Group type: EXPERIMENTAL
Intervention: Daily home PCA monitoring
Number of subjects: 4

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 4
Study: 10461058

Group type: EXPERIMENTAL
Intervention: Breast-conserving surgery (BCS)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Mastectomy (control group)
Number of subjects: 340
Study: 8891498

Group type: EXPERIMENTAL
Intervention: Cycling
Number of subjects: 6

Group type: COMPARATOR
Intervention: Running
Number of subjects: 6
Study: 6826111

Group type: EXPERIMENTAL
Intervention: 30 micrograms ethinyloestradiol plus 150 micrograms norgestrel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50 micrograms ethinyloestradiol plus 250 micrograms norgestrel
Number of subjects: 0

Group type: COMPARATOR
Intervention: 30 micrograms ethinyloestradiol alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: 30 micrograms ethinyloestradiol plus 2.5 mg norethisterone
Number of subjects: 0
Study: 31150063

Group type: EXPERIMENTAL
Intervention: Cold exposure in lean men
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cold exposure in men with obesity
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Lower critical temperature (Tlc) in lean men
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Lower critical temperature (Tlc) in men with obesity
Number of subjects: 21
Study: 30572923

Group type: EXPERIMENTAL
Intervention: Pre-operative stereotactic radiosurgery (SRS) followed by surgical resection
Number of subjects: 0
Study: 27751217

Group type: EXPERIMENTAL
Intervention: High-dose gamma globulin pulse therapy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 33
Study: 25404441

Group type: EXPERIMENTAL
Intervention: Peer Assisted Learning (PAL)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Expert Assisted Learning (EAL)
Number of subjects: 70
Study: 23224336

Group type: EXPERIMENTAL
Intervention: Diabetes management program
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 52
Study: 19890680

Group type: EXPERIMENTAL
Intervention: Robotic-assisted THA
Number of subjects: 130

Group type: COMPARATOR
Intervention: Hand-rasping THA
Number of subjects: 130
Study: 17555114

Group type: EXPERIMENTAL
Intervention: Human recombinant erythropoietic agents (specific dosage schemes not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Darbopoietin alpha (specific dosage schemes not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endogenous erythropoietin level (as a response-prediction factor)
Number of subjects: 0
Study: 16343114

Group type: EXPERIMENTAL
Intervention: Clindamycin 600 mg administered orally 1 hour before surgery
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo administered orally 1 hour before surgery
Number of subjects: 256
Study: 11966551

Group type: EXPERIMENTAL
Intervention: NO-generating system combined with lidocaine (5%)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo treatment (NO-generating gel)
Number of subjects: 100
Study: 9879477

Group type: EXPERIMENTAL
Intervention: Functional endoscopic sinus surgery (FESS)
Number of subjects: 50
Study: 7695460

Group type: EXPERIMENTAL
Intervention: Prevention Team group
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: Patient education group
Number of subjects: 803

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 803
Study: 1523211

Group type: EXPERIMENTAL
Intervention: Chorionic Villus Sampling (CVS)
Number of subjects: 2009

Group type: EXPERIMENTAL
Intervention: Amniocentesis
Number of subjects: 2009
Study: 6342359

Group type: EXPERIMENTAL
Intervention: Extensive radiation therapy (RT) followed by chemotherapy (CT)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Involved field RT, IF RT followed by CT, total nodal RT, or total lymphoid irradiation
Number of subjects: 164
Study: 31797710

Group type: EXPERIMENTAL
Intervention: Carnitine infusion over 10 min 2 hours prior to radiocontrast administration and 24 hours post CT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tadalafil administration 2 hours prior to radiocontrast administration and the subsequent day
Number of subjects: 0

Group type: COMPARATOR
Intervention: N-acetyl-L-cysteine treatment 1 day before and on the day of radiocontrast administration
Number of subjects: 0
Study: 29334403

Group type: EXPERIMENTAL
Intervention: Subepithelial connective tissue graft from tuberosity area (TG)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft from lateral palate (CG)
Number of subjects: 32
Study: 26146039

Group type: EXPERIMENTAL
Intervention: 300 g cooked African leafy vegetable (ALV) dish and school meal starch, five times per week for three months (n 86)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Normal school meal (n 81)
Number of subjects: 167
Study: 25060955

Group type: EXPERIMENTAL
Intervention: Fear-avoidance beliefs at baseline
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Fear-avoidance beliefs at 3-month follow-up
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Duration of complaints and baseline disability
Number of subjects: 90
Study: 22864376

Group type: EXPERIMENTAL
Intervention: Standard protocol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Minimized prescan adjustment protocol
Number of subjects: 10
Study: 20396716

Group type: EXPERIMENTAL
Intervention: Artrofoon
Number of subjects: 0
Study: 17976261

Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) preparation of racemic ibuprofen
Number of subjects: 12

Group type: COMPARATOR
Intervention: Immediate-release (IR) preparation of racemic ibuprofen
Number of subjects: 12
Study: 16390770

Group type: EXPERIMENTAL
Intervention: 1 mg/day 17beta-estradiol combined with 5 or 10 mg/day dydrogesterone
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: 2 mg/day 17beta-estradiol combined with 10 or 20 mg/day dydrogesterone
Number of subjects: 579

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 579
Study: 12581544

Group type: EXPERIMENTAL
Intervention: Celecoxib (200 mg/d to 400 mg/d)
Number of subjects: 2327
Study: 9467474

Group type: EXPERIMENTAL
Intervention: alfuzosin
Number of subjects: 205

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: TUMT (transurethral microwave thermotherapy, 52 degrees C for 60 min, microwave energy 200 kJ)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Boyarsky index
Number of subjects: 205
Study: 7533824

Group type: EXPERIMENTAL
Intervention: Oral vinorelbine (100 mg/m2/week or 80 mg/m2/week for prior radiation therapy patients)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Oral vinorelbine
Number of subjects: 162
Study: 2668524

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 94

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 94
Study: 824875

Group type: EXPERIMENTAL
Intervention: Short term treatment with Partusisten and Isoptin
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Short term treatment with Partusisten only
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Long term treatment with Partusisten and Isoptin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Long term treatment with Partusisten only
Number of subjects: 50
Study: 31527700

Group type: EXPERIMENTAL
Intervention: Hypnosis plus treatment-as-usual (EG, n=8)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Treatment-as-usual only (CG, n=10)
Number of subjects: 20
Study: 28322912

Group type: EXPERIMENTAL
Intervention: Maternal prenatal cortisol sampled on waking
Number of subjects: 216

Group type: COMPARATOR
Intervention: 30-min post-waking cortisol measure
Number of subjects: 216

Group type: COMPARATOR
Intervention: Evening cortisol measure
Number of subjects: 216
Study: 26002818

Group type: EXPERIMENTAL
Intervention: Progressive ICD programming
Number of subjects: 543

Group type: COMPARATOR
Intervention: Conventional ICD programming
Number of subjects: 543

Group type: EXPERIMENTAL
Intervention: Progressive ICD programming with dual-chamber detection devices
Number of subjects: 543
Study: 23683667

Group type: COMPARATOR
Intervention: Profluss® for 6 months (group I)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Profluss® + a-blockers for 3 months (group II)
Number of subjects: 168
Study: 21896650

Group type: EXPERIMENTAL
Intervention: Selenium 200 μg/d as selenomethionine
Number of subjects: 423

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 423
Study: 19193252

Group type: EXPERIMENTAL
Intervention: Training program in dementia care (three-month duration)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Relaxation group (RG)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Wait-list control group (CG)
Number of subjects: 96
Study: 17096032

Group type: COMPARATOR
Intervention: Antibiotic prophylaxis (exact dosage and duration not specified)
Number of subjects: 0

Group type: COMPARATOR
Intervention: First and second-generation cephalosporins (exact dosage and duration not specified)
Number of subjects: 0
Study: 15112940

Group type: EXPERIMENTAL
Intervention: Brief intervention approaches for hazardous drinking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motivational feedback on the college campus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individualized alcohol harm reduction feedback intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brief interventions
Number of subjects: 0
Study: 10899481

Group type: EXPERIMENTAL
Intervention: 20 microg ethinylestradiol (EE2) plus 75 microg gestodene (GES)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 30 microg ethinylestradiol (EE2) plus 75 microg gestodene (GES)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no contraception)
Number of subjects: 0
Study: 9285885

Group type: EXPERIMENTAL
Intervention: Zinc absorption from a standard breakfast labelled with 3 mg 67Zn.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intravenous administration of 0.5 mg 70Zn (as citrate).
Number of subjects: 20

Group type: COMPARATOR
Intervention: Urinary zinc excretion measurement.
Number of subjects: 20
Study: 8362773

Group type: EXPERIMENTAL
Intervention: Fosinopril (10 to 40 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Isradipine (5 to 20 mg)
Number of subjects: 19
Study: 3706857

Group type: EXPERIMENTAL
Intervention: External cardiac compression (ECC) performed at the lower one-third of the sternum 1.5 to 2 cm above the tip of the xiphoid
Number of subjects: 97

Group type: COMPARATOR
Intervention: External cardiac compression (ECC) performed at the midsternum at the level of the victim's nipples
Number of subjects: 97
Study: 30741868

Group type: EXPERIMENTAL
Intervention: 3 vs. 3 small-sided games (SSGs) for 3 × 2 minutes with 1 minute passive recovery
Number of subjects: 12

Group type: COMPARATOR
Intervention: Traditional warm-up strategies (specific handball shooting drills)
Number of subjects: 12
Study: 28965176

Group type: EXPERIMENTAL
Intervention: Pea protein added to chocolate beverage (24g)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rice protein added to chocolate beverage (24g)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oat protein added to chocolate beverage (24g)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Chocolate beverage alone (50g carbohydrate)
Number of subjects: 20
Study: 26676059

Group type: EXPERIMENTAL
Intervention: 16 weeks of supervised moderate intensity exercise training
Number of subjects: 21
Study: 24113628

Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate (PP)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Risperidone long-acting injection (RLAI)
Number of subjects: 334
Study: 24114665

Group type: EXPERIMENTAL
Intervention: Calcium supplements
Number of subjects: 4221

Group type: EXPERIMENTAL
Intervention: Vitamin D supplements
Number of subjects: 4221

Group type: EXPERIMENTAL
Intervention: Specific anti-osteoporotic drugs
Number of subjects: 4221

Group type: EXPERIMENTAL
Intervention: Any osteoporosis medication
Number of subjects: 4221

Group type: EXPERIMENTAL
Intervention: Specific anti-osteoporotic drug
Number of subjects: 4221

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 4221

Group type: EXPERIMENTAL
Intervention: Osteoporosis medication in women with major osteoporotic fracture
Number of subjects: 4221

Group type: EXPERIMENTAL
Intervention: Vitamin D use among specific osteoporosis drug users
Number of subjects: 4221
Study: 20934601

Group type: EXPERIMENTAL
Intervention: Passion fruit peel extract (PFP), 150 mg daily for 2 months
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 18589444

Group type: EXPERIMENTAL
Intervention: Thymus size measurement in children not vaccinated with Bacille Calmette‐Guérin (BCG) or vaccinated with BCG in the preceding 4 weeks
Number of subjects: 923

Group type: EXPERIMENTAL
Intervention: Thymus size measurement in children who had malaria or were treated with chloroquine or Quinimax in the previous week
Number of subjects: 923

Group type: EXPERIMENTAL
Intervention: Thymus size measurement controlling for background factors associated with thymus size and mortality
Number of subjects: 923
Study: 15800559

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (55% carbohydrate, 15% protein, 30% fat)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-protein diet (40% carbohydrate, 30% protein, 30% fat)
Number of subjects: 12
Study: 12803510

Group type: COMPARATOR
Intervention: lisinopril 10 mg/day
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: lisinopril 10 mg/day and pentoxifylline 600 mg/day for nine months
Number of subjects: 50
Study: 10327508

Group type: EXPERIMENTAL
Intervention: Rehabilitation-oriented approach (n = 30)
Number of subjects: 710

Group type: COMPARATOR
Intervention: Usual claim-based practice (Control group, n = 30)
Number of subjects: 710
Study: 8576508

Group type: EXPERIMENTAL
Intervention: Walking program (5 days/week for 12 weeks, max 30 minutes/day)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Social visit control group (weekly visits for 30 minutes)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Walking program (22 weeks)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Social visit control group (22 weeks)
Number of subjects: 41
Study: 1670062

Group type: EXPERIMENTAL
Intervention: Dialytic ultrafiltration
Number of subjects: 8

Group type: COMPARATOR
Intervention: Large-volume paracentesis
Number of subjects: 8
Study: 7056105

Group type: EXPERIMENTAL
Intervention: Oral verapamil therapy in chronic AF with rapid rate at rest
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Oral verapamil therapy in chronic AF with accelerated rate during exercise
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Oral verapamil therapy in paroxysmal AF
Number of subjects: 13
Study: 31088552

Group type: EXPERIMENTAL
Intervention: Unmarried marital status
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Mid upper arm circumference (MUAC) < 11 cm
Number of subjects: 413
Study: 28806366

Group type: EXPERIMENTAL
Intervention: Storytelling DVD intervention
Number of subjects: 619

Group type: COMPARATOR
Intervention: Didactic comparison DVD
Number of subjects: 619
Study: 26380238

Group type: EXPERIMENTAL
Intervention: Preemptive pudendal nerve block with 0.3 cc/kg bupivacaine 0.25%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups (sitting position)
Number of subjects: 60
Study: 25142999

Group type: EXPERIMENTAL
Intervention: Lopinavir-ritonavir (LPV-r) 400-100 mg twice/day for 29.5 days followed by P. ginseng 500 mg twice/day for 2 weeks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: P. ginseng 500 mg twice/day for 2 weeks
Number of subjects: 12
Study: 21070230

Group type: EXPERIMENTAL
Intervention: telcagepant 280/300 mg
Number of subjects: 1068

Group type: COMPARATOR
Intervention: rizatriptan 10 mg
Number of subjects: 1068
Study: 19524389

Group type: EXPERIMENTAL
Intervention: Brief, personally tailored counseling sessions based on lung functioning, CO exposure, and smoking-related health conditions.
Number of subjects: 536

Group type: COMPARATOR
Intervention: Generic smoking-risk information and personalized counseling about diet, BMI, and physical activity.
Number of subjects: 536
Study: 18614724

Group type: EXPERIMENTAL
Intervention: Solid dark chocolate (22 g cocoa powder)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sugar-free cocoa (22 g cocoa powder)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sugared cocoa (22 g cocoa powder)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Cocoa-free placebo bar (0 g cocoa powder)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (0 g cocoa powder)
Number of subjects: 45
Study: 15863986

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 100
Study: 12051570

Group type: EXPERIMENTAL
Intervention: 2 x 80 mg/day Ginkgo special extract EGb 761
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 10541424

Group type: EXPERIMENTAL
Intervention: Mizolastine 10 mg
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 375

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Mizolastine vs Cetirizine
Number of subjects: 375
Study: 7603600

Group type: EXPERIMENTAL
Intervention: Gadodiamide injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: Gd-DTPA
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both contrast media
Number of subjects: 60
Study: 2190933

Group type: EXPERIMENTAL
Intervention: Cefuroxime (one dose)
Number of subjects: 502

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 502
Study: 489772

Group type: EXPERIMENTAL
Intervention: Once-daily sotalol administration (80 to 320 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Twice-daily sotalol administration (80 to 320 mg)
Number of subjects: 30
Study: 30736977

Group type: EXPERIMENTAL
Intervention: Selective use of T-tube during CCS
Number of subjects: 405

Group type: COMPARATOR
Intervention: No T-tube placement (Control)
Number of subjects: 405
Study: 29070637

Group type: EXPERIMENTAL
Intervention: Active photobiomodulation therapy (PBMT)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Active PBMT
Number of subjects: 148
Study: 26382580

Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis, BB-12® (1 or 10 billion colony-forming units/d)
Number of subjects: 1248

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1248
Study: 23856779

Group type: EXPERIMENTAL
Intervention: Deleobuvir 100 mg q8h for 5 days
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Deleobuvir 200 mg q8h for 5 days
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Deleobuvir 400 mg q8h for 5 days
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Deleobuvir 800 mg q8h for 5 days
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Deleobuvir 1200 mg q8h for 5 days
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Deleobuvir 400 mg q8h for 5 days (for patients with cirrhosis)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Deleobuvir 600 mg q8h for 5 days (for patients with cirrhosis)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 21881539

Group type: EXPERIMENTAL
Intervention: 10-mg ramipril
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 21141020

Group type: EXPERIMENTAL
Intervention: 4-0 chromic catgut
Number of subjects: 50

Group type: COMPARATOR
Intervention: 4-0 silk
Number of subjects: 50
Study: 17372095

Group type: EXPERIMENTAL
Intervention: Duct tape occlusion therapy (moleskin with transparent duct tape)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Moleskin alone (control group)
Number of subjects: 90
Study: 14980943

Group type: EXPERIMENTAL
Intervention: Prophylactic infusion of IV phenylephrine at 100 microg/min for 3 min, then 100 microg/min as needed
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group receiving IV bolus phenylephrine 100 microg after each SAP <80% of baseline
Number of subjects: 50
Study: 11686857

Group type: EXPERIMENTAL
Intervention: Absolute Risk (AR)
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Number Needed to Treat (NNT)
Number of subjects: 457
Study: 9141377

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers (CCBs)
Number of subjects: 3400
Study: 8175974

Group type: EXPERIMENTAL
Intervention: Low dose human synthetic BNP infusion (4 pmol/kg.min for 1 h)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 3066519

Group type: EXPERIMENTAL
Intervention: Rifaximin (three 200 mg tablets/die for 7 days)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Rifaximin
Number of subjects: 121
Study: 29717483

Group type: EXPERIMENTAL
Intervention: Trauma-focused psychotherapy
Number of subjects: 88